07 February 2024 | Wednesday | News
Image Source : Public Domain
Migraine, recognized globally as a significant cause of disability, particularly among pre-menopausal women, poses a substantial health challenge. For around 2% of the world's population, migraine headaches escalate to chronic attacks, leading to debilitating symptoms such as intense headaches, nausea, and sensitivity to light for a minimum of 15 days each month. Existing treatments often fall short, highlighting the critical need for innovative solutions. In response, ShiraTronics has developed a system specifically engineered to address the debilitating symptoms faced by these patients.
The ShiraTronics System delivers precise electrical pulses tailored to disrupt migraine pain signals. This fully implantable, programmable device aims to offer patients and physicians a novel and potentially more effective treatment option.
Most Read
Bio Jobs
News